These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3878056)

  • 1. Deca-Durabolin and cytotoxic drugs.
    Turner R
    Acta Endocrinol Suppl (Copenh); 1985; 271():70-9. PubMed ID: 3878056
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic parameters of nandrolone (19-nortestosterone) after intramuscular administration of nandrolone decanoate (Deca-Durabolin) to healthy volunteers.
    Wijnand HP; Bosch AM; Donker CW
    Acta Endocrinol Suppl (Copenh); 1985; 271():19-30. PubMed ID: 3865478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hematological toxicity and nandrolone decanoate during polychemotherapy of bronchogenic carcinoma. Preliminary note].
    de Sanctis C; De Luca S; Succi A; Gargiulo P; Mugnaini L; Antilli A; Signora M; Cruciani AR
    Clin Ter; 1986 Aug; 118(3):183-6. PubMed ID: 3757462
    [No Abstract]   [Full Text] [Related]  

  • 4. Exuberant local tissue reaction to intramuscular injection of nandrolone decanoate (Deca-Durabolin)--a steroid compound in a sesame seed oil base--mimicking soft tissue malignant tumors: a case report and review of the literature.
    Khankhanian NK; Hammers YA; Kowalski P
    Mil Med; 1992 Dec; 157(12):670-4. PubMed ID: 1470383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of anabolic steroid on immune response].
    Yamagishi H; Kobayashi M; Konosu H; Kurioka H; Naito K; Sonoyama T; Nishimoto T; Hashimoto I
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):420-6. PubMed ID: 6367663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metastatic cancer.
    Spiers AS; DeVita SF; Allar MJ; Richards S; Sedransk N
    J Med; 1981; 12(6):433-45. PubMed ID: 7033426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
    Heinonen E; Alanko A; Gröhn P; Rissanen P
    Breast Cancer Res Treat; 1985; 5(1):75-80. PubMed ID: 3978249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nandrolone phenylpropionate (NSC-23162e) on the bone marrow suppression caused by cyclophosphamide (NSC-26271): a clinical trial.
    Burn JI; Cooke WM
    Cancer Chemother Rep; 1974; 58(6):867-70. PubMed ID: 4615786
    [No Abstract]   [Full Text] [Related]  

  • 9. Deca-Durabolin and parenteral nutrition in post-traumatic patients.
    Mosebach KO; Hausmann D; Caspari R; Stoeckel H
    Acta Endocrinol Suppl (Copenh); 1985; 271():60-9. PubMed ID: 3934896
    [No Abstract]   [Full Text] [Related]  

  • 10. THE USE OF TRENIMON AND DECA-DURABOLIN IN RECURRENT GYNAECOLOGICAL CARCINOMA.
    RAURAMO L; GROENROOS M
    Ann Chir Gynaecol Fenn; 1964; 53():115-9. PubMed ID: 14120480
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
    Gold J; High HA; Li Y; Michelmore H; Bodsworth NJ; Finlayson R; Furner VL; Allen BJ; Oliver CJ
    AIDS; 1996 Jun; 10(7):745-52. PubMed ID: 8805865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nandrolone decanoate on the repopulation of the thymus after total body irradiation of mice.
    Plum J; Huys J; De Scheerder Y; Dhont E; De Smedt M
    Immunopharmacology; 1982 Oct; 5(1):19-30. PubMed ID: 6752097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nandrolone phenpropionate on myelopoiesis.
    Kahn SB; Conroy JF; Brodsky I
    J Med; 1974; 5(6):303-9. PubMed ID: 4528544
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
    Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
    Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with supraphysiological doses of nandrolone decanoate reduces the sensitivity of Bezold-Jarisch reflex control of heart rate and blood pressure.
    Bissoli NS; Medeiros AR; Santos MC; Busato VC; Jarske RD; Abreu GR; Moysés MR; de Andrade TU
    Pharmacol Res; 2009 Jun; 59(6):379-84. PubMed ID: 19429469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of nandrolone decanoate (Deca-durabolin) on the peripheral conversion of androstenedione to oestrone.
    Andriesse R; Thussen JH; Donker GH
    J Steroid Biochem; 1977 Dec; 8(12):1271-2. PubMed ID: 592789
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of nandrolone decanoate in NZB/W mice treated concomitantly with maintenance doses of dexamethasone sodium phosphate.
    Verheul HA; Deckers GH; Schuurs AH
    Int J Immunopharmacol; 1985; 7(2):249-54. PubMed ID: 4008140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic steroid boosts weight.
    GMHC Treat Issues; 1996 Sep; 10(9):8-9. PubMed ID: 11363845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXPERIENCES ON DECA-DURABOLIN TREATMENT OF DIABETIC RETINOPATHY.
    OJALA L
    Acta Ophthalmol (Copenh); 1964; 42():519-22. PubMed ID: 14213940
    [No Abstract]   [Full Text] [Related]  

  • 20. [Do anabolic steroids protect bone marrow during cytostatic therapy?].
    Kopera H
    Med Klin; 1980 Jul; 75(15):539-43. PubMed ID: 7001201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.